Reshaping the Tumor Microenvironment of KRAS G12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 & MEK Inhibition for Improved Immunotherapy Response

Time: 2:45 pm
day: Day Two Track B PM

Speakers:

Bobby Norgard